Recent publications published by researchers at the MRC WIMM.
Tracking in situ checkpoint inhibitor-bound target T cells in patients with checkpoint-induced colitis.
Gupta T. et al, (2024), Cancer Cell, 42, 797 - 814.e15
Interferon-Gamma-Producing CD8+ Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor-Colitis.
Sasson SC. et al, (2021), Gastroenterology, 161, 1229 - 1244.e9
Spatiotemporal analysis of human intestinal development at single-cell resolution.
Fawkner-Corbett D. et al, (2021), Cell, 184, 810 - 826.e23
RODE: LEARNING ROLES TO DECOMPOSE MULTI-AGENT TASKS
Wang T. et al, (2021), ICLR 2021 - 9th International Conference on Learning Representations
Single-cell atlas of colonic CD8+ T cells in ulcerative colitis.
Corridoni D. et al, (2020), Nat Med, 26, 1480 - 1490
Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?
Cheung VTF. et al, (2020), Br J Cancer, 123, 207 - 215
Aortic valve area using computed tomography-derived correction factor to improve the validity of left ventricular outflow tract measurements.
Alskaf E. et al, (2020), Echocardiography, 37, 196 - 206
Immune checkpoint inhibitor-related colitis assessment and prognosis: can inflammatory bowel disease scoring point the way?
Cheung VTF. et al, (2020), JOURNAL OF CROHNS & COLITIS, 14, S286 - S288
Immunotherapy-related hepatitis: real-world experience from a tertiary centre.
Cheung V. et al, (2019), Frontline Gastroenterol, 10, 364 - 371
Randomized controlled study of the prediction of diminutive/small colorectal polyp histology using didactic versus computer-based self-learning module in gastroenterology trainees.
Smith SCL. et al, (2019), Dig Endosc, 31, 535 - 543
Immunotherapy-related hepatitis: real-world experience from a tertiary centre
CHEUNG VINCENT. et al, (2019), Frontline Gastroenterology
IMMUNOTHERAPY-RELATED GASTRITIS IN A TERTIARY ONCOLOGY CENTRE
Cheung V. et al, (2019), GUT, 68, A147 - A148
Real-world data: the incidence, diagnosis, and management outcomes of patients with immunotherapy-related colitis in two tertiary centres
Cheung V. et al, (2019), JOURNAL OF CROHNS & COLITIS, 13, S137 - S138
Tissue-based activation of mucosal-associated invariant T (MAIT) cells in combination ipilimumab and nivolumab checkpoint inhibitor (CI) colitis
Sasson SC. et al, (2019), ANNALS OF ONCOLOGY, 30, 530 - 530
ENDOSCOPIC CHARACTERISATION OF SMALL/DIMINUTIVE POLYPS BY GASTROENTEROLOGY TRAINEES: A COMPARISON BETWEEN THE NICE AND SIMPLE CLASSIFICATION
Smith SC. et al, (2018), GASTROINTESTINAL ENDOSCOPY, 87, AB520 - AB520
Incidence and management of immunotherapy-induced colitis in a tertiary melanoma and IBD centre: Clinical practice data
Cheung V. et al, (2018), JOURNAL OF CROHNS & COLITIS, 12, S198 - S198
INCIDENCE AND MANAGEMENT OF IMMUNOTHERAPY-INDUCED COLITIS IN A TERTIARY IBD CENTRE - CLINICAL PRACTICE DATA
Gupta T. et al, (2018), GUT, 67, A186 - A187